Skip to content
●  Nominations open · Transformational Leaders & Enterprises™ · Barcelona • London Nominate →

GCEIP 500 Global rank #111 · India

Cipla Limited: pharmaceuticals and the business behind its reach

Cipla develops and sells medicines, with a longstanding presence in respiratory care and generic pharmaceuticals.

Explore the company See recognition

Headquarters countryIndia
UN geographic regionAsiaSouthern Asia
Business sectorPharmaceuticals
GCEIP global rank#111See the global list for the current position.

The company

What it does

Cipla Limited operates in pharmaceuticals. Its business model, products and customers connect it to a wider market, with the company’s own disclosures providing the basis for understanding its activities and reach.

Across markets

The company supplies treatments in India and international markets, including medicines used for chronic respiratory conditions. Access depends on affordability, quality manufacturing and distribution, while clinical benefits are established through evidence for each medicine.

The company’s footprint and context are linked to the public sources below.

GCEIP view

What the record tells us

GCEIP sees Cipla’s contribution in making a broad portfolio of medicines available across markets. Its impact is clearest where reliable supply meets patient need at sustainable prices.

Published recognition

Selected results

See published awards and company-list results 1 sources
  • WCRC India's 50 Most Powerful Brands 2024–25 · 2025

    Corporate-brand research ranking; not a judged award. Company/brand attribution pending review.

    WCRC India Brand Power Index rank #45 of 50; published brand: Cipla

    View source
Transformational Leaders & Enterprises™ · Dubai • Barcelona • London Apply / Nominate